Jung-Bin Park

Jung-Bin Park

Auto-generated profile, based on publicly available information

Jung-Bin Park

Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in JAMA Dermatology
Verified
Journal Article
Open access
PDF file
KKKyu Han Kim
Kyu Han Kim
TCTae Hyun Choi
Tae Hyun Choi
YCYunhee Choi
Yunhee Choi
YPYoung Woon Park
Young Woon Park
KHKi Yong Hong
Ki Yong Hong
JJJAE HOON JEONG
JAE HOON JEONG
Infantile hemangioma (IH) is the most common tumor of infants and young children.1,2 Although small IH lesions typically do not cause problems, they often require treatment because of the site of occurrence and associated complications such as abnormal eye development or vision problems, airway obstruction, and bowel obstruction.3,4 Historically, steroids have been used as the primary treatment for IH.5,6 Steroids have been shown to be antiangiogenic in a number of in vitro settings and also have shown good therapeutic effects clinically. However, the use of steroids may lead to various complications including gastroesophageal reflux and growth disorders, although these complications are associated with long-term use and high dose.7 A type of anticancer drug or immunomodulator, interferon alfa, may be used for severe IH in cases where patients did not respond to steroids.8,9 However, interferon alfa also has several possible adverse effects, including fever, muscle pain, systemic myalgia, and in severe cases, liver damage, blood toxic effects, thyroid hormonal abnormality, and neurological and neurodevelopmental toxic effects.8 Because of concerns about these adverse effects, many guardians of pediatric patients prefer to wait rather than accept treatment.

1 April 2020 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
HYHyun-Kyu Yoon
Hyun-Kyu Yoon
HLHyung-Chul Lee
Hyung-Chul Lee
JPJung-Bin Park
Jung-Bin Park
HOHyongmin Oh
Hyongmin Oh
HPHee-Pyoung Park
Hee-Pyoung Park
BACKGROUND: Manual inline stabilization of the head and neck is a recommended maneuver for tracheal intubation in patients with a suspected cervical injury. However, because applying this maneuver inevitably restricts neck flexion and head extension, indirect intubating devices such as a videolaryngoscope or a video stylet could be required for successful tracheal intubation. In this study, we compared the clinical performance of the McGrath MAC videolaryngoscope versus the Optiscope video stylet in patients with manual inline cervical stabilization during tracheal intubation. METHODS: In 367 consecutive patients undergoing elective cervical spine surgery, tracheal intubation was randomly performed with manual inline stabilization using either the McGrath MAC videolaryngoscope (group M, n = 183) or the Optiscope video stylet (group O, n = 184) by 2 experienced anesthesiologists in a single institution. The primary outcome was the first-attempt success rate of tracheal intubation. Secondary outcomes were intubation time and the incidence of postoperative airway complications, such as sore throat, hoarseness, blood in the oral cavity, and blood staining on the endotracheal tube. RESULTS: The first-attempt success rate of tracheal intubation was significantly higher in group M compared with group O (92.3% vs 81.0%; risk difference [95% confidence interval], 0.11 [0.05–0.18]; P = .002). The intubation time was significantly shorter in group M than in group O (35.7 ± 27.8 vs 49.2 ± 43.8; mean difference [95% confidence interval], 13.5 [5.9–21.1]; P = .001). The incidence of postoperative airway complications was not significantly different between the 2 groups. CONCLUSIONS: The McGrath MAC videolaryngoscope showed a higher first-attempt success rate for tracheal intubation and a shorter intubation time than the Optiscope video stylet in cervical spine patients with manual inline stabilization during tracheal intubation. These results suggest that the McGrath MAC videolaryngoscope may be a better option for tracheal intubation in such patients.

1 April 2016 in Pediatric Critical Care Medicine
Verified
Journal Article
Closed access
JPJung-Bin Park
Jung-Bin Park
ISIn-Kyung Song
In-Kyung Song
JLJi-Hyun Lee
Ji-Hyun Lee
EKEun-Hee Kim
Eun-Hee Kim
HKHee-Soo Kim
Hee-Soo Kim
JKJin-Tae Kim
Jin-Tae Kim
Objectives: Few studies have examined cardiopulmonary resuscitation for patients with congenital heart disease, although they are at a high risk of cardiac arrest. Therefore, this study investigated the optimal chest compression position in patients with a single ventricle while providing them with basic life support. Design: This is a retrospective study of patients with a single ventricle who are undergoing chest CT. Setting: Tertiary teaching children’s hospital. Patients: A total of 185 patients with a single ventricle, including 73 patients before a bidirectional cavopulmonary shunt, 61 patients after a bidirectional cavopulmonary shunt, and 51 patients after the Fontan operation. Interventions Chest CT scans were reviewed. Measurements and Main Results: Sternal length was defined as the distance from the suprasternal notch to the xiphisternal junction. The optimal level of external cardiac compression was defined as the level at which the cross-sectional area of the systemic ventricle was the largest. The distance from the suprasternal notch to this level over the sternum was calculated. The structures below the intermammary line, the lower half and the lower third of the sternum, and the optimal level were determined. The level with the largest cross-sectional area of the ventricle was approximately the lower fourth of the sternum in all surgical stages: 86.5% ± 4.9% of the sternal length from the suprasternal notch before bidirectional cavopulmonary shunt, 85.9% ± 4.8% after bidirectional cavopulmonary shunt, and 86.4% ± 6.3% after the Fontan operation. The liver was not identified at any level, whereas the ascending aorta was detected in 2.2%, 3.8%, and 24.9% at the level of the lower third of the sternum, the intermammary line, and the lower half of the sternum, respectively. Conclusions: The optimal compression position in patients with a single ventricle is approximately 5–25% of the lower sternum. The optimal compression level for patients with a single ventricle is lower than that suggested in current guidelines for the normal population.

15 August 2009 in Natural Product Research
Verified
Journal Article
Closed access
JBJeen-Soo Bae
Jeen-Soo Bae
JPJin Wook Park
Jin Wook Park
SPSo Hyun Park
So Hyun Park
JPJung Bin Park
Jung Bin Park
YRYoon-Hwa Rho
Yoon-Hwa Rho
YBYoung-Seuk Bae
Young-Seuk Bae
A chloroform extract of the edible mushroom Pleurotus eryngii showed an inhibitory effect on mammalian DNA topoisomerase I. The topoisomerase I inhibitory compound was purified and identified as ubiquinone-9. Ubiquinone-9 was shown to inhibit the activity of topoisomerase I with IC50 of about 50 µM. Concentration of 110 µM ubiquinone-9 caused 50% growth inhibition of human leukaemia U937 cells, but not that of normal fibroblast NIH3T3 and 3Y1 cells. Ubiquinone-9-induced cell death was characterised with the cleavage of poly (ADP-ribose) polymerase and pro-caspase 3. Furthermore, ubiquinone-9 induced the fragmentation of DNA into an apoptotic DNA ladder, indicating that the inhibitor triggered apoptosis. The induction of apoptosis by ubiquinone-9 was also confirmed using flow cytometry analysis. Taken together, these results suggest that ubiquinone-9 may function by inhibiting oncogenic disease, at least in part, through the inhibition of topoisomerase I activity.

1 October 2024 in Korean Journal of Anesthesiology
Verified
Journal Article
Open access
PDF file
YJYoung-Eun Jang
Young-Eun Jang
JPJung-Bin Park
Jung-Bin Park
PKPyoyoon Kang
Pyoyoon Kang
SJSang-Hwan Ji
Sang-Hwan Ji
HKHee-Soo KIM
Hee-Soo KIM
JKJin-Tae Kim
Jin-Tae Kim
Background: This study aimed to investigate the risk factors for chloral hydrate sedation failure and complications in a tertiary children’s hospital in South Korea.Methods: A retrospective analysis of pediatric procedural sedation with chloral hydrate between January 1, 2021, and March 30, 2022, was performed. The collected data included patient characteristics, sedation history, and procedure. Multivariable regression analysis was performed to identify the risk factors for procedural sedation failure and complications.Results: A total of 6,691 procedural sedation were included in the analysis; sedation failure following chloral hydrate (50 mg/kg) occurred in 1,457 patients (21.8%) and was associated with a higher rate of overall complications compared to those with successful sedation (17.5% [225/1457] vs. 6.2% [322/5234]; P < 0.001, odds ratio: 3.236). In the multivariable regression analysis, the following factors were associated with increased risk of sedation failure: general ward or intensive care unit inpatient (compared with outpatient); congenital syndrome; oxygen dependency; history of sedation failure or complications with chloral hydrate; procedure more than 60 min; and magnetic resonance imaging, radiotherapy, or procedures with painful or intense stimuli (all P values < 0.05). Factors contributing to the complications included general ward inpatient, congenital syndromes, congenital heart disease, preterm birth, oxygen dependency, history of complications with chloral hydrate, and current sedation failure with chloral hydrate (all P values < 0.05).Conclusions: To achieve successful sedation with chloral hydrate, the patient’s sedation history, risk factors, and the type and duration of the procedure should be considered.

9 September 2025 in Anesthesiology
Verified
Journal Article
Closed access
SJSang-Hwan Ji
Sang-Hwan Ji
PKPyoyoon Kang
Pyoyoon Kang
SCSung-Ae Cho Sung-Ae Cho
Sung-Ae Cho Sung-Ae Cho
JPJung-Bin Park
Jung-Bin Park
YJYoung-Eun Jang
Young-Eun Jang
JLJi-Hyun Lee
Ji-Hyun Lee
Background: Anesthetic exposure in young children raises concerns about neurodevelopmental safety, with preclinical evidence suggesting potential neurotoxicity of volatile anesthetics. This study aimed to assess whether the combination of dexmedetomidine and remifentanil, by reducing sevoflurane exposure, has any differential effect on neurodevelopmental outcomes in young children compared with sevoflurane alone. Methods: This study was a prospective, double-blind, randomized clinical trial including children younger than 2 yr undergoing nonstaged, nonrepetitive surgeries. Participants received dexmedetomidine and remifentanil as adjuncts to sevoflurane (DEX-R group) or sevoflurane alone (control group). The study assessed their neurodevelopmental status at 28 to 30 months using the Korean Leiter International Performance Scale and the Child Behavior Checklist, as predefined secondary outcomes. The primary endpoint—full-scale IQ at 5 yr of age—will be reported after completion of long-term follow-up. Results: Among 400 enrolled participants, 343 completed assessments (169 control, 176 DEX-R). There was no difference in the mean anesthesia duration between the control and DEX-R groups (77.1 min vs. 72.8 min; mean difference [95% CI], 4.4 [−3.8 to 12.6]; P = 0.293). The mean end-tidal sevoflurane concentration was significantly lower in the DEX-R group than in the control group (1.8 vol% vs. 2.6 vol%; mean difference [95% CI], −0.9 [−1.0 to −0.7] vol%; P < 0.001). The mean full-scale IQ score was 102.5 ± 11.5 in the DEX-R group and 103.6 ± 11.5 in the control group (mean difference, −1.1; 95% CI, −3.9 to 1.7; P = 0.442). No significant difference was observed in the Child Behavior Checklist total score between groups. Conclusions: The addition of dexmedetomidine and remifentanil to sevoflurane anesthesia was not associated with significant differences in neurodevelopmental outcomes at 28 to 30 months compared to sevoflurane alone.